Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Our AI ranks Cabot Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Cabot Corp is a mid-cap company with a market capitalization of $3.90B. It ranks number 2 by market capitalization among the 9 Miscellaneous Chemical Products issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for CBT is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CBT included.
Follow CBT free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Miscellaneous Chemical Products peers listed below that report each metric.
| Metric | CBT | Rank |
|---|---|---|
| Market Cap | $3.90B | 2/9 |
| P/E Ratio | 20.51x | – |
| P/B Ratio | 2.43x | 4/8 |
| Dividend Yield | 2.49% | – |
| EPS | $3.56 | – |
| Book Value/Share | $31.09 | – |
| Revenue/Share | $70.38 | – |
| FCF/Share | $5.44 | – |
| Metric | CBT | Rank |
|---|---|---|
| ROE | 11.8% | 3/7 |
| ROA | 4.8% | 3/8 |
| ROIC | 17.4% | 4/9 |
| Gross Margin | 22.7% | 7/9 |
| Operating Margin | 13.6% | 2/9 |
| Net Margin | 5.2% | 4/8 |
| EBT Margin | 11.5% | 2/9 |
| Tax Rate | 45.5% | – |
| Metric | CBT | Rank |
|---|---|---|
| Current Ratio | 1.47x | 6/9 |
| Quick Ratio | 0.97x | 6/9 |
| D/E Ratio | 1.40x | 2/8 |
| Financial Leverage | 2.48x | 2/8 |
| Interest Coverage | 5.4x | 3/8 |
| Working Capital | $530M | 2/9 |
| Metric | CBT | Rank |
|---|---|---|
| Operating Cash Flow | $497M | 1/9 |
| Free Cash Flow | $281M | 1/5 |
| Capital Spending | -$216M | 5/5 |
| OCF Growth YoY | -23.5% | 4/7 |
| FCF Growth YoY | -19.2% | – |
| FCF/Sales | 7.7% | 2/5 |
| CapEx/Sales | 5.9% | 2/5 |
| Metric | CBT | Rank |
|---|---|---|
| Asset Turnover | 0.91x | 5/7 |
| Inventory Turnover | 5.0x | 4/9 |
| Fixed Assets Turnover | 2.1x | 5/7 |
| Days Inventory | 74 days | 6/9 |
| Payables Period | 87 days | 4/9 |
| Metric | CBT | Rank |
|---|---|---|
| Total Revenue | $3.63B | 1/7 |
| Operating Income | $493M | 1/9 |
| Net Income | $190M | 1/8 |
| R&D Expense | $55M | 2/8 |
| SG&A Expense | $277M | 2/7 |
| Cost of Goods Sold | $2.81B | 1/9 |
| Metric | CBT | Rank |
|---|---|---|
| Dividends Per Share | $1.88 | – |
| Payout Ratio | 52.8% | – |
| Shares Outstanding | 52M | – |
| Total Current Assets | $1.67B | 41.9% of assets |
| Cash & Short-term Investments | $250M | 6.3% of assets |
| Inventory | $566M | 14.2% of assets |
| Total Liabilities | $2.24B | 56.4% of assets |
| Short-term Debt | $465M | 11.7% of assets |
Companies classified under the same SEC industry code as Cabot Corp (Miscellaneous Chemical Products): 9 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CBT Cabot Corp | ▼ | $3.90B |
| ESI Element Solutions Inc | ▶ | $9.06B |
| WDFC Wd 40 Co | ▶ | $2.74B |
| FTK Flotek Industries Inc/Cn/ | ▲ | $980M |
| ASPI Asp Isotopes Inc. | ▼ | $350M |
| OEC Orion S.A. | ▲ | $326M |
| ARQ Arq, Inc. | ▲ | $86M |
| FSI Flexible Solutions International Inc | ▶ | $78M |
| PURE Pure Bioscience, Inc. | ▲ | $10M |
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Sean Keohane, Cabot President and Chief Executive Officer commented: “I am pleased with our second quarter financial performance where we delivered Adjusted Earnings Per Share of $1.90 which was up 7% ...
Our AI ranks Cabot Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
A per-ticker accuracy statistic for CBT is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Cabot Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
9 issuers in our coverage, CBT included, share the SEC industry code Miscellaneous Chemical Products. The largest are: Element Solutions Inc (ESI), Wd 40 Co (WDFC), Flotek Industries Inc/Cn/ (FTK), Asp Isotopes Inc. (ASPI), Orion S.A. (OEC), Arq, Inc. (ARQ).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.